KAM
BIIB icon

Kazazian Asset Management’s Biogen BIIB Stock Holding History

Kazazian Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-150
Closed -$2K – 43
2016
Q2 		$2K Buy
+150
New +$39.5K ﹤0.01% 59

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Kazazian Asset Management's BIIB Position: Q3 2019 in Review

Kazazian Asset Management held its Biogen (BIIB) position steady in Q3 2019 at 6,974 shares worth $1.62M. The position accounts for 2.19% of the portfolio, ranked #16.

Kazazian Asset Management first reported a position in BIIB in Q2 2016 and has held it in 14 quarters since. The position peaked at $6.39M in Q2 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Kazazian Asset Management held 6,974 shares of Biogen worth $1.62M as of Q3 2019.
  • Kazazian Asset Management left its Biogen share count unchanged in Q3 2019.
  • Biogen made up 2.19% of Kazazian Asset Management's portfolio in Q3 2019, its #16 holding.
  • Kazazian Asset Management first reported a position in Biogen in Q2 2016 and has held it in 14 quarters since.
  • Kazazian Asset Management's Biogen position peaked at $6.39M in Q2 2018.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Kazazian Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.